UK markets closed

Renalytix Plc (RNLX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.6288+0.0047 (+0.75%)
At close: 04:00PM EDT
0.6388 +0.01 (+1.59%)
After hours: 07:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
2,410
3,403
2,970
1,491
0
Cost of revenue
2,227
2,683
2,096
804
0
Gross profit
183
720
874
687
0
Operating expenses
Research development
-
14,298
14,648
10,040
4,565
Selling general and administrative
28,566
28,662
39,524
15,436
5,750
Total operating expenses
38,670
42,941
54,057
33,298
10,315
Operating income or loss
-38,487
-42,221
-53,183
-32,611
-10,315
Interest expense
-
-
2
3
2
Total other income/expenses net
-
-
-
-
-63
Income before tax
-42,243
-45,605
-45,251
-35,788
-9,844
Income tax expense
3
2
25
-4,778
0
Income from continuing operations
-42,246
-45,607
-45,276
-31,010
-9,844
Net income
-42,246
-45,607
-45,276
-31,010
-9,844
Net income available to common shareholders
-42,246
-45,607
-45,276
-31,010
-9,844
Basic EPS
-1.00
-1.10
-1.24
-0.86
-0.34
Diluted EPS
-1.00
-1.10
-1.34
-0.86
-0.34
Basic average shares
43,600
41,105
36,431
35,742
29,540
Diluted average shares
43,600
41,105
36,919
35,742
29,540